Similar articles for PMID: 15288143

Year	Number of Results
1955	1
1967	1
1971	1
1972	1
1985	2
1988	1
1989	1
1990	3
1991	3
1992	8
1993	10
1994	13
1995	12
1996	11
1997	13
1998	12
1999	10
2000	12
2001	10
2002	20
2003	19
2004	20
2005	17
2006	14
2007	14
2008	17
2009	10
2010	23
2011	13
2012	14
2013	12
2014	11
2015	6
2016	6
2017	4
2018	4
2019	5
2020	2
2021	1
2022	1
2024	0

1

In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.

Tong Z, Yamaki T, Harada K, Houkin K. Tong Z, et al. Magn Reson Imaging. 2004 Sep;22(7):1017-24. doi: 10.1016/j.mri.2004.02.007. Magn Reson Imaging. 2004. PMID: 15288143

2

In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.

Tong Z, Yamaki T, Harada K, Houkin K. Tong Z, et al. Magn Reson Imaging. 2004 Jun;22(5):735-42. doi: 10.1016/j.mri.2004.02.006. Magn Reson Imaging. 2004. PMID: 15172069

3

Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.

Tong ZY, Toshiaki Y, Wang YJ. Tong ZY, et al. Chin Med J (Engl). 2005 Aug 5;118(15):1251-7. Chin Med J (Engl). 2005. PMID: 16117877

4

[Diagnosis of brain tumor with proton MR spectroscopy--the quantification of gliomas compared with normal brain].

Yu HW, Tanabe S, Yamaki T, Harada K, Hashi K. Yu HW, et al. No Shinkei Geka. 2000 Dec;28(12):1063-9. No Shinkei Geka. 2000. PMID: 11193526 Japanese.

5

Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.

Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH. Server A, et al. Acta Radiol. 2010 Apr;51(3):316-25. doi: 10.3109/02841850903482901. Acta Radiol. 2010. PMID: 20092374

6

MR spectroscopic evaluation of brain tissue damage after treatment for pediatric brain tumors.

Blamek S, Larysz D, Ficek K, Sokół M, Miszczyk L, Tarnawski R. Blamek S, et al. Acta Neurochir Suppl. 2010;106:183-6. doi: 10.1007/978-3-211-98811-4_33. Acta Neurochir Suppl. 2010. PMID: 19812945

7

Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.

Stadlbauer A, Moser E, Gruber S, Buslei R, Nimsky C, Fahlbusch R, Ganslandt O. Stadlbauer A, et al. Neuroimage. 2004 Oct;23(2):454-61. doi: 10.1016/j.neuroimage.2004.06.022. Neuroimage. 2004. PMID: 15488395

8

High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging.

Ziegler A, von Kienlin M, Décorps M, Rémy C. Ziegler A, et al. Cancer Res. 2001 Jul 15;61(14):5595-600. Cancer Res. 2001. PMID: 11454713

9

Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.

Magalhaes A, Godfrey W, Shen Y, Hu J, Smith W. Magalhaes A, et al. Acad Radiol. 2005 Jan;12(1):51-7. doi: 10.1016/j.acra.2004.10.057. Acad Radiol. 2005. PMID: 15691725

10

White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?

Fayed N, Morales H, Modrego PJ, Muñoz-Mingarro J. Fayed N, et al. Acad Radiol. 2006 Feb;13(2):229-35. doi: 10.1016/j.acra.2005.10.016. Acad Radiol. 2006. PMID: 16428059

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

327 results

Results by year